| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |